Knott David M Jr
- SEC CIK
- 0001892770
- Latest filing
- Aug 12, 2026
INZY holding history
Inozyme Pharma, Inc. in every 13F filed by Knott David M Jr, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
INZY overviewAll 13F holders of INZYFull Q2 2026 holdings
- Shares (Q3 2025)
- 0
- Sold out in Q3 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 10
- Since Q1 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2025 | 0 | $0 | 0.0% | −666,204−100.0% | Sold out | Holders |
| Q2 2025 | 666,204 | $2.66M | 1.2% | 00.0% | Unchanged | Holders |
| Q1 2025 | 666,204 | $606.2K | 0.3% | −28,796−4.1% | Reduced | Holders |
| Q4 2024 | 695,000 | $1.93M | 0.7% | +130,451+23.1% | Added | Holders |
| Q3 2024 | 564,549 | $2.95M | 1.2% | 00.0% | Unchanged | Holders |
| Q2 2024 | 564,549 | $2.52M | 1.0% | 00.0% | Unchanged | Holders |
| Q1 2024 | 564,549 | $4.32M | 1.5% | 00.0% | Unchanged | Holders |
| Q4 2023 | 564,549 | $2.40M | 0.9% | +110,541+24.3% | Added | Holders |
| Q3 2023 | 454,008 | $1.91M | 0.8% | +234,008+106.4% | Added | Holders |
| Q2 2023 | 220,000 | $1.23M | 0.5% | +60,000+37.5% | Added | Holders |
| Q1 2023 | 160,000 | $917.0K | 0.4% | +160,000 | New | Holders |